Product Highlight - ROCURONIUM B. BRAUN SOLUTION FOR INJECTION/INFUSION
01 Dec 2021
An easy-to-use neuromuscular blocking agent with rapid onset
• Patented non-cooling formulation1,2
• Needle-free handling
• Fastest onset of all non-depolarizing neuromuscular blocking agents3
• Intermediate duration of action4
References: 1. Rocuronium B. Braun Solution for Injection/Infusion 50mg/5ml Hong Kong prescribing information. B. Braun Medical (HK) Ltd. Version July 2020. 2. European Patent Office. European Patent Specification (EP2900216B1): Stabilized aqueous compositions of neuromuscular blocking agents. 3. Kim YB, et al. Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents. Korean J Anesthesiol. 2017 Oct; 70(5): 500–510. 4. Lien C, Eikermann M. (2019). 22 - Neuromuscular Blockers and Reversal Drugs. In H. Hemmings & T. Egan (Eds.), Pharmacology and Physiology Anesthesia (Second Edition). Elsevier. pp. 428-454.